Oral leukoplakias: To treat or not?

Oral Oncology

Volumn 33, Issue 5, 1997, Pages 317-321

  Tradati, N ^a   Grigolat, R ^b   Calabrese, L ^a   Costa, L ^b   Giugliano, G ^a   Morelli, F ^b   Scully, C ^a,c   Boyle, P ^a,c   Chiesa, F ^a,c  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b National Tumour Institute   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Chemoprevention; Diagnosis; Oral leukoplakias; Surgery; Treatment

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; FENRETINIDE; ISOTRETINOIN; RETINOID;

CANCER PREVENTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; LEUKOPLAKIA; MALIGNANT TRANSFORMATION; MOUTH CANCER; PRECANCER; PRIORITY JOURNAL; REVIEW; TOPICAL DRUG ADMINISTRATION; TREATMENT INDICATION;

EID: 0031414734     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(97)00016-X     Document Type: Article

References (61)

1. Bloom, J. R., Early detection of cancer. Psychologic and social dimension. Cancer, 1994, 74(Suppl.), 1464 s-1473 s.
2. WHO. Collaborating Centre for Oral Precancerous Lesions. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surgery, 1978, 46, 518-539.
3. Schepman, K. P. and Waal van der, I., A proposal for classification and staging system for oral leukoplakia: a preliminary study. Oral Oncology, European Journal of Cancer, 1995, 31B, 396-398.
4. Bouquot, J. E. and Whitaker, S. B., Oral leukoplakia: rationale for diagnosis and prognosis of its clinical subtypes or "phases". Quintessence International, 1994, 25, 133-140.
5. McCarthy, F. P., Etiology, pathology and treatment of leukoplakia buccalis, with report of 316 cases. Archives of Dermatology and Syphilology, 1936, 34, 612-623.
6. Sciubba, J. J., Oral leukoplakia. Critical Reviews of Oral Biology and Medicine, 1995, 6, 147-160.
7. Szpirglas, H., Dètèction des cancers buccaux et conception actuelle des ètats prècancereux. Revue de Praticien, 1995, 45, 831-837.
8. Wright, J. M., Oral precancerous lesions and conditions. Seminars in Dermatology, 1994, 13, 125-131.
9. Sankaranarayanan, R., Nair, M. K., Mathew, B., Balaram, P., Sebastian, P. and Dutt, S. C., Recent results of oral cancer research in Kerala, India. Head and Neck, 1992, 14, 107-112.
10. Ikeda, N., Ishii, T., Iida, S. and Kawai, T., Epidemiological study of oral leukoplakia based on mass screening for oral mucosal diseases in a selected Japanese population. Community Denial and Oral Epidemiology, 1991, 19, 160-164.
11. Chiesa, F., Tradati, N., Sala, L., et al., Follow-up of oral leukoplakia after carbon dioxide laser surgery. Archives of Otolaryngology Head and Neck Surgery, 1990, 116, 177-180.
12. Bouquot, J. E., Weiland, L. H. and Kurland, L. T., Leukoplakia and carcinoma in situ synchronously associated with invasive oral/oropharyngeal carcinoma in Rochester, Minn., 1935-1984. Oral Surgery, Oral Medicine. Oral Pathology, 1988, 65, 199-204.
13. Abdel-Salam, M., Mayall, B., Chew, K., Silverman, S. Jr and Greenspan, J. S., Prediction of malignant transformation in oral epithelial lesions by image cytometry. Cancer, 1988, 62, 1981-1987.
14. Silverman, S. JrJr, Gorsky, M. and Lozada, F., Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer, 1984, 53, 563-568.
15. Banoczy, J., Follow-up studies in oral leukoplakia. Journal of Maxillofacial Surgery, 1977, 5, 69-75.
16. Waldron, C. A. and Shaffer, W. G., Leukoplakia revisited: a clinicopathologic study of 3256 oral leukoplakias. Cancer, 1975, 36, 1386-1392.
17. Lumerman, H., Freedman, P. and Kerpel, S., Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surgery, Oral Medicine, Oral Pathology, 1995, 79, 321-329.
18. 2 laser on an out-patient basis: a useful procedure for prevention and early detection of oral carcinomas. Tumori, 1986, 72, 307-312.
19. Scully, C. and Cawson, R. A., Potentially malignant oral lesions. Journal of Epidemiology and Biostatistics, 1996, 1, 3-12.
20. Woodruff, M. F. A., Tumor clonality and its biological significance. Advances in Cancer Research, 1988, 50, 197-229.
21. Sakr, W. A., Zarbo, R. J., Jacobs, J. R. and Crissman, I. D., Distribution of basement membrane in squamous cell carcinoma of the head and neck. Human Pathology, 1987, 18, 1043-1050.
22. Richard, R. M., Cervical intraepithelial neoplasia. Pathology Animal, 1973, 8, 301-328.
23. Foulds L. Neoplastic Development. Academic Press, New York, 1969.
24. Crissman, I. D., Visscher, D. W. and Sakr, M. I., Premalignant lesions of the upper aerodigestive tract: pathologic classification. Journal of Cell Biochemistry, 1993, 17(Suppl.), 49s-56s.
25. Crissman, J. D., Gnepp, D. R., Goodman, M. L., Hellquist, H. and Johns, M. E., Preinvasive lesions of the upper aerodigestive tract: histologic definitions and clinical implications (a symposium). Pathology Annual, 1987, 22, 311-352.
26. Scully, C. and Field, J., Genetic aberrations in squamous cell carcinoma of the head and neck (SCCHN) with reference to oral carcinoma. International Journal of Oncology, 1997, 10, 5-21.
27. Scully, C. and Burkhardt, A., Tissue markers of potentially malignant human oral epithelial lesions. Journal of Oral Pathology and Medicine, 1993, 22, 246-255.
28. Ropka, M. E., Goodwin, J., Levine, P. A., Sasaki, C. T., Kirchner, J. C. and Cantrell, R. W., Effective head and neck tumor markers. Archives of Otolaryngology Head and Neck Surgery, 1991, 117, 1011-1014.
29. Abbey, L. M., Kaugars, G. E., Gunsolley, J. C., et al., Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics, 1995, 80, 188-191.
30. Karabulut, A., Reibel, J., Therkildsen, M. H., Praetorius, F., Nielsen, H. W. and Dabelsteen, E., Observer variability in the histologic assessment of oral premalignant lesions. Journal of Pathology and Medicine, 1995, 24, 198-200.
31. Boone, C. W. and Kellof, F. G. J., Development of surrogate endpoint biomarkers for clinical trials of cancer chemopreventive agents: relationship to fundamental properties of preinvasive (intraepithelial) neoplasia. Journal of Cell Biochemistry, 1994, 19(Suppl.), 10s-22s.
32. Huber, M. H. and Hong, W. K., Biology and chemoprevention of head and neck cancer. Current Problems in Cancer, 1994, 18, 83-141.
33. Scully, C., Oral precancer: preventive and medical approaches to management. Oral Oncology, European Journal of Cancer, 1995, 31B, 16-26.
34. Mashberg, A. and Samit, A., Early diagnosis of asymptomatic oral and oropharyngeal squamous cell cancers. CA, 1995, 45, 328-351.
35. Mashberg, A. and Meyers, H., Anatomical site and size of 222 early asymptomatic oral squamous cell carcinomas: a continuing prospective study of oral cancer II. Cancer, 1973, 32, 1436-1445.
36. Silverman, S. Jr, Migliorati, C. and Barbosa, J., Toluidine blue staining in the detection of oral precancerous and malignant lesions. Oral Surgery, Oral Medicine, Oral Pathology, 1984, 57, 379-382.
37. Caspersson, T. and Santesson, L., Studies on protein metabolism in the cells of epithelial tumours. Acta Radiologica, 1942, 46, 17-18.
38. Pearse A. G. E. Histochemistry, Theoretical and Applied. Brown and Company, Boston, 1968.
39. Silverman, S., Barbosa, J. and Kearns, G., U1-transtructural and histochemical localization of glycogen in human normal and hyperkeratotic oral epithelium. Archives of Oral Biology, 1971, 16, 423-434.
40. Epstein, J. B., Scully, C. and Spinelli, J., Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. Oral Pathology Medicine, 1992, 21, 160-163.
41. Gupta, P. C., Murti, P. R., Bhonsle, R. B., Metha, F. S. and Pindborg, J. J., Effect of cessation of tobacco use on the incidence of oral mucosa lesions in a 10-yr follow-up study of 12,212 users. Oral Diseases, 1995, 1, 54-58.
42. Epstein, J. B., Wong, F. L., Millner, A. and Le, N. D., Topical bleomycin treatment of oral leukoplakia: a randomized double-blind clinical trial. Head and Neck, 1994, 16, 539-544.
43. Boisnic, S., Branchet, M. C., Pascal, F., Ben-Slama, L., Rostin, M. and Spirzglas, H., Tretinoine topique dans le traitement des lichens plans et des leucoplasies de la muqueuse buccale. Evaluation clinique. Annales de Dermatologie et de venereologie, 1994, 121, 459-463.
44. Tradati, N., Chiesa, F., Rossi, N., et al., Successful topical treatment of oral lichen planus and leukoplakias with fenretinide (4-HPR). Cancer Letters, 1994, 76, 109-111.
45. Downer, M. C., Evans, A. W., Hallet, C. M. H., Jullien, J. A., Speight, P. M. and Zakrzewska, J. M., Evaluation of screening for oral cancer and precancer in a company headquarters. Community Dental and Oral Epidemiology, 1995, 23, 84-88.
46. Jullien, J. A., Zakrzewska, J. M., Downer, M. C. and Speight, P. M., Attendance and compliance at an oral cancer screening programme in a general medical practice. Oral Oncology, European Journal of Cancer, 1995, 31B, 202-206.
47. Speight, P. M., Zakrzewska, J. and Downer, M. C., Screening for oral cancer and precancer. Oral Oncology, European Journal of Cancer, 1992, 28B, 45-48.
48. Marteau, T. M., Screening in practice. Reducing the psychological costs. British Medical Journal, 1990, 301, 26-28.
49. Chiesa, F., Boracchi, P., Tradati, N., et al., Risk of preneoplastic and neoplastic events in operated oral leukoplakias. Oral Oncology, European Journal of Cancer, 1993, 29B, 23-28.
50. Chiesa, F., Tradati, N., Marazza, M., et al., Fenretinide (4-HPR) in chemoprevention of oral leukoplakia. Journal of Cell Biochemistry, 1993, 17F(Suppl.), 255s-261s.
51. Hong, W. K.., Endicott, J., Itri, L. M., et al., 13-cis-retinoic acid in the treatment of oral leukoplakia. New England Journal of Medicine, 1986, 315, 1501-1505.
52. Richtsmeier, W. J., Biologic modifiers and chemoprevention of cancer of the oral cavity. New England Journal of Medicine, 1993, 328, 58-59.
53. Lippman, S. M., Batsakis, J. G., Toth, B. B., et al., Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. New England Journal of Medicine, 1993, 328, 15-20.
54. Hong, W. K., Lippman, S. M. and Wolf, G. T., Recent advances in head and neck cancer - larynx preservation and cancer chemoprevention: the seventeenth annual Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Research, 1993, 53, 5113-5120.
55. Garewell, H. S., Potential role of β-carotene in prevention of oral cancer. American Journal of Clinical Nutrition, 1991, 53, 294s-297s.
56. Garewal, H., Chemoprevention of oral cancer: beta-carotene and vitamin E in leukoplakia. European Journal of Cancer Prevention, 1994, 3, 101-107.
57. Omenn, G. S., Goodman, G., Thornquist, M., et al., The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Research, 1994, 54(Suppl.), 2038s-2043s.
58. Itri, L. M., Cancer chemoprevention. Cancer, 1993, 72(Suppl.), 3374s-3380s.
59. The alpha-tocopherol, beta-carotene cancer prevention study group. New England Journal of Medicine 1994, 330, 1029-1035.
60. NCI (Bethesda) Press Conference, January 18, 1996.
61. Boyle, P., Chiesa, F. and Scully, C., Chemoprevention and oral cancer: (More) trials and (more) tribulations). Oral Oncology, European Journal of Cancer, 1995, 31B, 1-2.